Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMID 16130503)

Published in Lupus on January 01, 2005

Authors

T Atsumi1, S Furukawa, O Amengual, T Koike

Author Affiliations

1: Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan. at3tat@med.hokudai.ac.jp

Articles by these authors

(truncated to the top 100)

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67

Editorial: The First Specialist Qualification Examination of the Japanese Society of Intravascular Neurosurgery (JSIN). Interv Neuroradiol (2004) 3.03

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet (1990) 2.87

Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J Immunol (1996) 2.83

Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol (1984) 2.43

Crossed aphasia elicited by direct cortical stimulation. Neurology (2006) 2.15

Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut (2000) 2.06

Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene (1995) 2.05

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis (2010) 2.04

Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther (2015) 2.01

Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis (2007) 2.01

Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol (1990) 1.94

Specificity of mouse hybridoma antibodies to DNA. Immunol Lett (1982) 1.93

Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus. Clin Exp Immunol (1982) 1.90

Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg (1994) 1.87

Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes (1987) 1.86

Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am Heart J (1973) 1.83

Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum (1996) 1.78

Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol (1996) 1.76

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med (1994) 1.74

Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem (1991) 1.73

Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proc Natl Acad Sci U S A (2003) 1.69

Natural history of intracranial cavernous malformations. J Neurosurg (1995) 1.64

Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. J Thorac Cardiovasc Surg (1997) 1.59

Unilateral adrenalectomy improves insulin resistance and polycystic ovaries in a middle-aged woman with virilizing adrenocortical adenoma complicated with Cushing's syndrome. J Endocrinol Invest (2007) 1.57

Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol (1998) 1.54

Up-regulated tissue factor expression in antiphospholipid syndrome. Thromb Haemost (1997) 1.52

Neurotoxicity of human eosinophils towards peripheral nerves. J Neurol Sci (1989) 1.52

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol (1998) 1.49

IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus. J Rheumatol (1998) 1.49

Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) (2008) 1.48

Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol (1992) 1.47

Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand (1993) 1.47

Advanced glycation endproducts and diabetic nephropathy. J Diabetes Complications (1996) 1.47

Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum (1997) 1.45

Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation (1996) 1.45

Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg (1996) 1.44

Haemophagocytic syndrome in a patient with dermatomyositis. Br J Rheumatol (1998) 1.43

The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut (2005) 1.42

The cadherin-like protein is essential to specificity determination and cytotoxic action of the Bacillus thuringiensis insecticidal CryIAa toxin. FEBS Lett (1999) 1.42

Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med (2000) 1.42

Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost (2001) 1.41

Radio-ulnar synostosis, short stature, microcephaly, scoliosis, and mental retardation. Am J Med Genet (1995) 1.40

Development of bronchial asthma after wheezing associated with respiratory infection in infancy. Acta Paediatr (1995) 1.40

Effect of beta 2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system. Lupus (1997) 1.40

Myocardial oxygen utilization after reversible global ischemia. J Thorac Cardiovasc Surg (1990) 1.40

A clinicopathological study of dissecting aneurysms of the intracranial vertebral artery. J Neurosurg (1991) 1.40

Off-pump extraction of an embedded high posterior left ventricular bullet utilizing a new cardiac stabilization device. J Trauma (2001) 1.39

Amiodarone for atrial fibrillation during off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2001) 1.39

Superantigens and Kawasaki disease. Immunol Today (1991) 1.39

Granular lymphocyte proliferative disorder after autologous peripheral blood stem cell transplantation for multiple myeloma. Eur J Haematol (2003) 1.39

Alanylglutamine-enriched total parenteral nutrition improves protein metabolism more than branched chain amino acid-enriched total parenteral nutrition in protracted peritonitis. J Trauma (1997) 1.39

Stress platelets in normal individuals and patients with idiopathic thrombocytopenic purpura. Blood Cells (1992) 1.39

Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun (2000) 1.38

A rise of erythrocytes and platelets in a patient with myelodysplastic syndrome during the administration of G-CSF. Am J Hematol (1992) 1.37

Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol (1999) 1.35

Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience (2003) 1.34

Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum (2000) 1.32

A knowledge model for analysis and simulation of regulatory networks. Bioinformatics (2000) 1.31

T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J Clin Invest (1992) 1.31

Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: regulation by transforming growth factor beta and serum factors. Proc Natl Acad Sci U S A (1988) 1.29

Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.29

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis/encephalopathy. Neurology (1998) 1.27

Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int Immunol (1994) 1.27

Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob Agents Chemother (2001) 1.26

Anomalous origin of anterior choroidal artery. Neuroradiology (1989) 1.26

Radiologic and histopathologic evaluation of canine artery occlusion after collagen-coated platinum microcoil delivery. AJNR Am J Neuroradiol (1999) 1.25

Phenotypes and invariant alpha beta TCR expression of peripheral V alpha 14+ NK T cells. J Immunol (1997) 1.23

Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg (2001) 1.22

Expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sjögren's syndrome. Arthritis Rheum (1994) 1.22

Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol (2005) 1.21

Angiographic follow-up study of cerebral arteriovenous malformations with reference to their enlargement and regression. Neurosurgery (1989) 1.19

Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand J Gastroenterol (2000) 1.19

Washout measurement of radioisotope implanted by radioactive beams in the rabbit. Phys Med Biol (2003) 1.17

Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome. J Immunol (1992) 1.16

Perineural spread of adenoid cystic carcinoma in the oral and maxillofacial regions: evaluation with contrast-enhanced CT and MRI. Dentomaxillofac Radiol (2012) 1.16

Relationship between resting hypercapnia and physiologic parameters before and after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.16

Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg (1996) 1.16

Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its' intracellular expression in human megakaryocytes. Blood (1999) 1.15

Cloning, sequencing, and expression of the Bombyx mori receptor for Bacillus thuringiensis insecticidal CryIA(a) toxin. Biosci Biotechnol Biochem (1998) 1.15

Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. Blood (1997) 1.15

Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood (1999) 1.14

Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. Br J Rheumatol (1998) 1.14

Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys (2001) 1.13

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia (1999) 1.13

'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus (2011) 1.13

A "calcium set-point hypothesis" of neuronal dependence on neurotrophic factor. Exp Neurol (1992) 1.13

Stacking properties of a highly hydrophobic dinucleotide sequence, N6, N6-dimethyladenylyl(3' leads to 5')N6, N6-dimethyladenosine, occurring in 16--18-S ribosomal RNA. Eur J Biochem (1980) 1.12

Effect of aeration and unsaturated fatty acids on expression of the Saccharomyces cerevisiae alcohol acetyltransferase gene. Appl Environ Microbiol (1997) 1.12

Molecular definition of human beta 2-glycoprotein I (beta 2-GPI) by cDNA cloning and inter-species differences of beta 2-GPI in alternation of anticardiolipin binding. Int Immunol (1991) 1.12

Prognosis of resected non-small cell lung cancer patients with carcinomatous pleuritis of minimal disease. Lung Cancer (2001) 1.12

Predominant expansion of V gamma 9/V delta 2 T cells in a tularemia patient. Infect Immun (1992) 1.12

Histological interaction of cultured endothelial cells and endovascular embolic materials coated with extracellular matrix. J Neurosurg (1997) 1.11

Molecular cloning and characterization of a novel gene, CORS26, encoding a putative secretory protein and its possible involvement in skeletal development. J Biol Chem (2000) 1.11

Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. Arthritis Rheum (1999) 1.11

A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J Clin Endocrinol Metab (1997) 1.09

T cell receptor V beta repertoire of double-negative alpha/beta T cells in patients with systemic sclerosis. Arthritis Rheum (1992) 1.09

Neurotoxicity of advanced glycation end-products for cultured cortical neurons. J Neuropathol Exp Neurol (2000) 1.09

Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg (1997) 1.08